Merger and acquisition (M&A) activity in the global healthcare sector should continue to rise next year, led by healthcare companies rather than private equity, according to a survey of industry executives. The report, published by investment bank Jefferies on Tuesday, surveyed 600 senior leaders in the sector. It found 68% of respondents expected the volume of deals in healthcare to rise in 2024, with 60% believing companies within the sector will dominate the transactions. The volume of M&A deals in the healthcare sector has surged 22% to $341 billion so far this year, according to data provider Dealogic, bucking a decline in M&A activity across most industries.
Read the full article: Healthcare Execs Expect M&A Activity to Rise Again in 2024 – Survey //
Source: https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-execs-expect-ma-activity-rise-again-2024-survey-2023-11-14